Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
255 participants
OBSERVATIONAL
2018-05-15
2019-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Flow Nasal Cannula in Immediately Post Extubation
NCT03495947
High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure.
NCT04609462
HFNC and Acute Hypercapnic Respiratory Failure
NCT04109560
Conduct of Nasal High Flow Oxygen in Acute Respiratory Failure
NCT03311087
High-flow Nasal Cannula Oxygen Therapy With or Without NIV During the Weaning Period
NCT03121482
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Nasal Flow Therapy
Every patient in the ICU that requires High Nasal Flow Therapy
No intervention
No intervention, observational study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention, observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to medical or surgical ICU
* Requirement of high nasal flow therapy
Exclusion Criteria
* Patient unable to protect airway
* Diagnosed shock
* Glasgow equal or under 8
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundación Santa Fe de Bogota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leopoldo Ferrer
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leopoldo E Ferrer, MD
Role: PRINCIPAL_INVESTIGATOR
Fundación Santa Fe de Bogotá
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fundación Santa Fe de Bogotá
Bogotá, Bogota D.C., Colombia
Hospital Departamental de Nariño
Nariño, Pasto, Colombia
Medicina Intensiva del Tolima
Ibagué, Tolima Department, Colombia
Clinica Reina Sofia
Bogotá, , Colombia
Instituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavarez (INCART)
Santo Domingo, , Dominican Republic
Fundación Medica Sur
Mexico City, Mexico City, Mexico
Hospital del Mar - Parc de Salut Mar
Barcelona, , Spain
MD Anderson Cancer Center
Madrid, , Spain
Hospital Ramon y Cajal
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCEI-7327-2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.